Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: A possible role in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 43, Issue 5, 2000, Pages 1134-1144

  Jovanovic, Dragan V ^a   Martel Pelletier, Johanne ^a   Di Battista, John A ^a   Mineau, François ^a   Jolicoeur, François Cyril ^a   Benderdour, Mohamed ^a   Pelletier, Jean Pierre ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; PROTEIN KINASE INHIBITOR; STAT PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

EID: 0034041595     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200005)43:5<1134::aid-anr24>3.0.co;2-%23     Document Type: Article

References (65)

1. Hale LP, Haynes BF. Pathology of rheumatoid arthritis and associated disorders. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 993-1016.
2. Klimiuk PA. Goronzy JJ. Bjornsson J, Bcckcnhaugh RD. Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 1997;151:1311-9.
3. Martel-Pelletier J. Di Battista JA, Lajeunesse D. Biochemical factors in joint articular tissue degradation in osteoarthritis. In: Reginster JY. Pelletier JP, Martel-Pelletier J, Henrotin Y, editors. Osteoarthritis: clinical and experimental aspects. Berlin: Springer-Verlag: 1999, p. 156-87.
4. Kingsley GH, Panayi GS. Joint destruction in rheumatoid arthritis: biological bases. Clin Exp Rheumatol 1997;15:S3-14.
5. Boots AM, Wimmers-Bertens AJ. Rijnders AW. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology 1994;82:268-74.
6. Thomas R, Davis LS, Lipsky PE. Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994;152:2613-23.
7. Firestein GS, Alvaro-Gracia JM, Maki R, Alvaro-Gracia JMAG. Quantitative analysis of cytokine gene expression in rheumatoid arthritis [published erratum appears in J Immunol 1990;145:1037]. J Immunol 1990;144:3347-53.
8. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994;53:39-44.
9. Burmester GR, Stuhlmüller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis: mastermind or work-horse in arthritis? Arthritis Rheum 1997;40:5-18.
10. Dayer JM. Cytokines and anti-cytokines in inflammatory rheumatism. Rev Rhum 1994;61:173S-80S.
11. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-62.
12. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 1989;48:645-53.
13. Welgus HG, Campbell EJ, Bar-Shavil Z, Senior RM, Teitelbaum SL. Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest 1985;76:219-24.
14. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-41.
15. Hibbs MS, Hoidal JR, Kang AH. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest 1987;80: 1644-50.
16. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, et al. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988;263: 6579-87.
17. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989;264:17213-21.
18. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 1996;39:1576-87.
19. Grillet B, Dequeker J, Paemen L, van Damme B, Opdenakker G. Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody. Br J Rheumatol 1997;36:744-7.
20. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, et al. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995;155:5483-6.
21. Jovanovic D, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, et al. Interleukin-17 (IL-17) stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160:3513-21.
22. Shulom-Barak T, Quach J, Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB. J Biol Chem 1998; 273:27467-73.
23. Martel-Pelletier J, Mineau F, Jovanovic D, Di Battista JA, Pelletier J-P. Mitogen-activated protein kinase and nuclear factor κB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes: possible role of transactivating factor mitogen-activated protein kinase-activated protein kinase (MAPKAPK). Arthritis Rheum 1999;42:2399-2409.
24. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999;162:2347-52.
25. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J Immunol 1999;162:494-502.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
28. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52.
29. Hunter T. Signal transduction: cytokine connections. Nature 1993; 366:114-6.
30. Bennett SB, Por S, Stanley ER, Breit SN. Monocyte proliferation in cytokine-free, serum-free system. J Immunol 1992;153:201-12.
31. Koolwijk P, Miltenberg AMM, van Erek MGM, Oudshoorn M, Niedbala MJ, Breedveld FC, et al. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis: correlation with clinical and experimental variables of inflammation. J Rheumatol 1995;22: 385-93.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
33. Stahle-Backdahl M, Sudbeek BD, Eisen AZ, Welgus HG, Parks WC. Expression of 92-kDa type IV collagenase mRNA by cosinophils associated with basal cell carcinoma. J Invest Dermatol 1942;99:497-503.
34. Pang L, de las Heras B, Hoult JR. A novel diterpenoid labdane from Sideritis javalambrensis inhibits cicosanoid generation from stimulated macrophages hut enhances arachidonate release. Biochem Pharmacol 1996;51:863-8.
35. Miller C, Zhang M, He Y, Zhao J, Pelletier JP. Martel-Pelletier J. et al. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J Cell Biochem 1998;69:392-413.
36. Murphy G, Reynolds JJ, Extracellular matrix degradation. In: Royce PM, Steinmann B, editors. Connective tissue and its heritable disorders. New York: Wiley-Liss; 1993. p. 187.
37. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
38. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-70.
39. Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maat C, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoetic cytokines. J Exp Med 1996;183:2593-603.
40. Chabaud M, Fossiez F, Taupin JL, Miossee P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998;161:409-14.
41. Dudler J, Busso N, Péclat V, Lotz M, So A. In vivo effects of murine recombinant interleukin-17 on synovial joint in mice [abstract]. Arthritis Rheum 1997:40 Suppl 9:S273.
42. Tetlow LC, Lees M, Ogata Y, Nagase H, Woolley DE. Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int 1993;13:53-9.
43. Unemori EN, Hibbs MS, Amento EP. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 1991;88:1656-62.
44. Saren P, Welgus HG, Kovanen PT. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996;157:4159-65.
45. Leber TM, Balkwill FR. Regulation of monocyte MMP-9 production by TNF-α and a tumour-derived soluble factor (MMPSF). Br J Cancer 1998;78:724-32.
46. Ismair MO, Ries C, Lottspeich F, Zang C, Kolb HJ, Petrides PE. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-α (TNF-α) in NB4 leukemic cells: specific involvement of TNF receptor type 1. Leukemia 1998;12:1136-43.
47. Fieren MW. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. Blood Purif 1996;14:179-87.
48. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JF. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
49. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362: 248-50.
50. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclcar phagocytes. J Clin Invest 1995;96: 2304-10.
51. Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992;90:382-8.
52. Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM. Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 1997;173:327-34.
53. Shapiro SD, Kobayashi DK, Pentland AP, Welgus HG. Induction of macrophage metalloproteinases by extracellular matrix: evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J Biol Chem 1993;268: 8170-5.
54. Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM. Interleukin 10 suppression of monocyte prostaglandin H synthase-2: mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 1994;269:21322-9.
55. Mackenzie R, Coles GA, Topley N, Powell WS, Williams JD. Down-regulation of cyclooxygenase product generation by human peritoneal macrophages. Immunology 1992;76:648-54.
56. Haskill S, Johnson C, Eierman D, Becker S, Warren K. Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 1988;140:1690-4.
57. Krautwald S. IL-16 activates the SAPK signaling pathway in CD4+ macrophages. J Immunol 1998;160:5874-9.
58. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA. Ahmad MF, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1904;369:156-60.
59. Subramaniam SV, Pearson LL, Adunyah SE. Interleukin-17 induces rapid tyrosine phosphorylation and activation of Raf-1 kinase in human monocytic progenitor cell line U937. Biochem Biophys Res Commun 1999;259:172-7.
60. Awane M, Andres PG, Li DJ, Reinecker HC. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol 1999;162:5337-44.
61. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. Induction of proto-oncogcne JUN/AP-1 by serum and TPA. Nature 1988; 334:629-31.
62. Fini ME, Bartlett JD, Matsubani M, Rinehart WB, Mody MK, Girard MT, et al. The rabbit gene for 92-kDa matrix metalloproteinase: role of AP1 and AP2 in cell type-specific transcription. J Biol Chem 1994:269:28620-8.
63. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JF. Jr, et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995;181:1755-62.
64. Samelson LE, Klausner RD. Tyrosine kinases and tyrosine-based activation motifs: current research on activation via the T cell antigen receptor. J Biol Chem 1992;267:24913-6.
65. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-21.